Day: December 18, 2019

LINCOLNTON, N.C., Dec. 18, 2019 (GLOBE NEWSWIRE) — Carolina Trust BancShares, Inc. (“Carolina Trust”) (NASDAQ: CART), the parent company of Carolina Trust Bank, announced today the receipt of required shareholder approval to consummate its previously announced merger with Carolina Financial Corporation, Charleston, South Carolina (“Carolina Financial”) (NASDAQ: CARO).  At a shareholders’ meeting held on December 18, 2019, Carolina Trust’s shareholders approved the merger agreement and the merger of Carolina Trust with and into Carolina Financial.  With respect to the merger proposal, 99% of the shares voted at the meeting were cast in favor of the proposal to approve the merger agreement with Carolina Financial.The merger, which has received all required regulatory approvals, is expected...

HOUSTON, Dec. 18, 2019 (GLOBE NEWSWIRE) — Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced that William Pate, President & Chief Executive Officer, will attend the Goldman Sachs Global Energy Conference 2020 in Miami, FL on January 8, 2020.  Mr. Pate will participate in a panel discussion and 1×1 meetings. About Par PacificPar Pacific Holdings, Inc. (NYSE: PARR), headquartered in Houston, Texas, owns and operates market-leading energy and infrastructure businesses. Par Pacific’s strategy is to acquire and develop energy and infrastructure businesses in logistically complex markets.  Par Pacific owns and operates one of the largest energy networks in Hawaii with 148,000-bpd of combined refining capacity, a logistics system supplying the major islands of the state...

IRONWOOD, Mich., Dec. 18, 2019 (GLOBE NEWSWIRE) — Keweenaw Land Association, Limited (OTC: KEWL) (“Keweenaw” or the “Company”) announced today that its Board of Directors has authorized a stock repurchase program.  Under this program, Keweenaw may repurchase up to $1 million in aggregate value of its shares of Common Stock.In connection with the repurchase program, Keweenaw has entered into a 10b5-1 plan during an open trading window while it was not in possession of material non-public information to facilitate the repurchases of its Common Stock.  The shares may be repurchased from time to time in open market transactions at prevailing market prices or by other means in accordance with federal securities laws. The actual timing, number and value of shares repurchased under the program will be determined...

– Upsized Initial Public Offering raises $97.6 million in gross proceeds –– BIO89-100 continues to advance in Phase 1b/2a NASH study –SAN FRANCISCO, Dec. 18, 2019 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today reported its financial results for the quarter ended September 30, 2019.“I am proud of what the 89bio team has accomplished with the successful completion of our IPO and the advancement of BIO89-100 in the Phase 1b/2a NASH study,” said Rohan Palekar, Chief Executive Officer of 89bio. “With our strengthened capital position, we look forward to continuing to advance BIO89-100 through clinical development...

IRVINE, Calif., Dec. 18, 2019 (GLOBE NEWSWIRE) — Kura Sushi USA, Inc. (“Kura Sushi” or the “Company”), (NASDAQ: KRUS), a fast-growing technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss first quarter 2020 financial results on Wednesday, January 8, 2020 at 5:00 p.m. ET. A press release with first quarter 2020 financial results will be issued that same day after the market close.  Hosting the conference call and webcast will be Hajime “Jimmy” Uba, President and Chief Executive Officer, and Koji Shinohara, Chief Financial Officer.Interested parties may listen to the conference call via telephone by dialing 201-689-8471. A telephone replay will be available shortly after the call has concluded and can be accessed by dialing 412-317-6671;...

WILMINGTON, Del., Dec. 18, 2019 (GLOBE NEWSWIRE) — WSFS Bank, the primary subsidiary of WSFS Financial Corporation (Nasdaq: WSFS), has partnered with and sponsored newly opened REC Philly, in the Fashion District of Philadelphia, which provides resources and work space for Philadelphia’s art community.  Part creative incubator, part creative agency, REC is a physical space, digital application, and creator community designed and dedicated to providing its members with the resources, education & opportunities to build sustainable & scalable businesses around their talent.“As an advocate of the arts in Philadelphia, WSFS was immediately drawn to REC Philly’s mission, and we recognize the unique value they provide for creators of all kinds,” said Justin Dunn, Senior Vice President and Chief Marketing...

OMAHA, Neb., Dec. 18, 2019 (GLOBE NEWSWIRE) — On December 18, 2019, America First Multifamily Investors, L.P.’s (NASDAQ: ATAX) (the “Partnership”) announced it has moved its Schedule K-1 information to a “new and improved” website.  The Partnership’s unitholder K-1 information is now available using the Tax Package Support website at www.taxpackagesupport.com/ATAX. The website previously used to access Partnership Schedule K-1 information is no longer available.The new website contains various features designed to enhance the user experience and make it easier for unitholders to access their Schedule K-1 information.  In addition, the new website is compatible with most web browsers and may also be accessed using mobile devices.Further information can be found on the “K-1 Information”...

MIN-117 study did not meet its primary (MADRS) and key secondary (HAM-A) endpointsMIN-117 was generally well-tolerated with a safety profile comparable to placeboCompany to host conference call at 5:00 p.m. today (dial-in information below)WALTHAM, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, announced today the Phase 2b trial of MIN-117 in adult patients suffering from moderate to severe major depressive disorder (MDD) and presenting with symptoms of anxious distress failed to meet its primary and key secondary endpoints.Neither dose of MIN-117 tested in this trial showed a statistically significant separation from placebo on the reduction in the symptoms of MDD...